Cobenfy Interactions
There are 387 drugs known to interact with Cobenfy (trospium/xanomeline), along with 7 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 5 are major, 366 are moderate, and 16 are minor.
- View all 387 medications that may interact with Cobenfy
- View Cobenfy alcohol/food interactions (2)
- View Cobenfy disease interactions (7)
Most frequently checked interactions
View interaction reports for Cobenfy (trospium / xanomeline) and the medicines listed below.
- Abilify (aripiprazole)
- albuterol
- buspirone
- cannabis
- Caplyta (lumateperone)
- cetirizine
- clonazepam
- clozapine
- cyclobenzaprine
- doxycycline
- gabapentin
- hydroxyzine
- Ingrezza (valbenazine)
- lamotrigine
- lithium
- lorazepam
- melatonin
- metformin
- mirtazapine
- omeprazole
- oxycodone
- pantoprazole
- propranolol
- risperidone
- rosuvastatin
- topiramate
- trazodone
- Vitamin D3 (cholecalciferol)
- Vraylar (cariprazine)
- Wegovy (semaglutide)
Cobenfy alcohol/food interactions
There are 2 alcohol/food interactions with Cobenfy (trospium / xanomeline).
Cobenfy disease interactions
There are 7 disease interactions with Cobenfy (trospium / xanomeline) which include:
- gastrointestinal retention
- narrow angle glaucoma
- urinary retention
- hepatic impairment
- alcoholism
- hepatic impairment
- renal impairment
Report options
QR code containing a link to this page
More about Cobenfy (trospium / xanomeline)
- Cobenfy consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: psychotherapeutic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
